Prostaglandin analog or intraocular pressure-lowering agent

This page covers all Prostaglandin analog or intraocular pressure-lowering agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Phase 3 pipeline (1)

• DE-130A/DE-130A · Santen SAS · Ophthalmology
  DE-130A is a topical ophthalmic agent designed to reduce intraocular pressure in glaucoma and ocular hypertension.

Patent intelligence

• prostaglandin analog or intraocular pressure lowering agent patent landscape — aggregated cliff calendar, attackable patents, originator estates